Becton, Dickinson and Company (0R19.L)
0R19.L Stock Price Chart
Explore Becton, Dickinson and Company interactive price chart. Choose custom timeframes to analyze 0R19.L price movements and trends.
0R19.L Company Profile
Discover essential business fundamentals and corporate details for Becton, Dickinson and Company (0R19.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
5 Nov 2014
Employees
70.00K
Website
https://www.bd.comCEO
Thomas E. Polen Jr.
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
0R19.L Financial Timeline
Browse a chronological timeline of Becton, Dickinson and Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 6 Nov 2025
Upcoming earnings on 7 Aug 2025
Revenue estimate is $5.50B.
Dividend declared on 9 Jun 2025
A dividend of $1.04 per share was announced, adjusted to $1.04. The dividend was paid on 30 Jun 2025.
Earnings released on 1 May 2025
EPS came in at $3.35 surpassing the estimated $3.28 by +2.13%, while revenue for the quarter reached $5.27B, missing expectations by -4.14%.
Dividend declared on 10 Mar 2025
A dividend of $1.04 per share was announced, adjusted to $1.04. The dividend was paid on 31 Mar 2025.
Earnings released on 5 Feb 2025
EPS came in at $1.04 falling short of the estimated $2.98 by -65.10%, while revenue for the quarter reached $5.17B, beating expectations by +1.33%.
Dividend declared on 9 Dec 2024
A dividend of $1.04 per share was announced, adjusted to $1.04. The dividend was paid on 31 Dec 2024.
Earnings released on 7 Nov 2024
EPS came in at $3.81 surpassing the estimated $3.77 by +1.06%, while revenue for the quarter reached $5.44B, beating expectations by +1.06%.
Dividend declared on 9 Sept 2024
A dividend of $0.95 per share was announced, adjusted to $0.95. The dividend was paid on 30 Sept 2024.
Earnings released on 1 Aug 2024
EPS came in at $1.68 falling short of the estimated $3.31 by -49.24%, while revenue for the quarter reached $4.99B, missing expectations by -1.71%.
Dividend declared on 10 Jun 2024
A dividend of $0.95 per share was announced, adjusted to $0.95. The dividend was paid on 28 Jun 2024.
Earnings released on 2 May 2024
EPS came in at $1.85 falling short of the estimated $2.97 by -37.71%, while revenue for the quarter reached $5.05B, beating expectations by +0.15%.
Earnings released on 13 Mar 2024
EPS came in at $0.96 falling short of the estimated $2.40 by -59.83%, while revenue for the quarter reached $4.71B, missing expectations by -0.56%.
Dividend declared on 7 Mar 2024
A dividend of $0.95 per share was announced, adjusted to $0.95. The dividend was paid on 29 Mar 2024.
Earnings released on 11 Dec 2023
EPS came in at $0.37 falling short of the estimated $3.42 by -89.21%, while revenue for the quarter reached $5.09B, beating expectations by +1.33%.
Dividend declared on 7 Dec 2023
A dividend of $0.95 per share was announced, adjusted to $0.95. The dividend was paid on 29 Dec 2023.
Dividend declared on 7 Sept 2023
A dividend of $0.91 per share was announced, adjusted to $0.91. The dividend was paid on 29 Sept 2023.
Earnings released on 3 Aug 2023
EPS came in at $1.41 falling short of the estimated $2.91 by -51.55%, while revenue for the quarter reached $4.88B, beating expectations by +0.80%.
Dividend declared on 8 Jun 2023
A dividend of $0.91 per share was announced, adjusted to $0.91. The dividend was paid on 30 Jun 2023.
Earnings released on 4 May 2023
EPS came in at $1.61 falling short of the estimated $2.74 by -41.24%, while revenue for the quarter reached $4.82B, beating expectations by +2.82%.
Dividend declared on 9 Mar 2023
A dividend of $0.91 per share was announced, adjusted to $0.91. The dividend was paid on 31 Mar 2023.
Earnings released on 2 Feb 2023
EPS came in at $1.78 falling short of the estimated $2.68 by -33.58%, while revenue for the quarter reached $4.59B, beating expectations by +1.26%.
Dividend declared on 8 Dec 2022
A dividend of $0.91 per share was announced, adjusted to $0.91. The dividend was paid on 30 Dec 2022.
Earnings released on 2 Nov 2022
EPS came in at $1.00 falling short of the estimated $2.74 by -63.50%, while revenue for the quarter reached $4.76B, beating expectations by +1.09%.
Dividend declared on 8 Sept 2022
A dividend of $0.87 per share was announced, adjusted to $0.87. The dividend was paid on 30 Sept 2022.
Earnings released on 3 Aug 2022
EPS came in at $1.36 falling short of the estimated $2.50 by -45.60%, while revenue for the quarter reached $4.64B, beating expectations by +3.84%.
Dividend declared on 8 Jun 2022
A dividend of $0.87 per share was announced, adjusted to $0.87. The dividend was paid on 30 Jun 2022.
Earnings released on 4 May 2022
EPS came in at $1.58 falling short of the estimated $2.93 by -46.08%, while revenue for the quarter reached $5.01B, beating expectations by +3.34%.
Dividend declared on 9 Mar 2022
A dividend of $0.87 per share was announced, adjusted to $0.87. The dividend was paid on 31 Mar 2022.
Earnings released on 3 Feb 2022
EPS came in at $2.36 falling short of the estimated $2.78 by -15.11%, while revenue for the quarter reached $5.00B, beating expectations by +4.87%.
Dividend declared on 9 Dec 2021
A dividend of $0.87 per share was announced, adjusted to $0.87. The dividend was paid on 31 Dec 2021.
Earnings released on 4 Nov 2021
EPS came in at $1.80, while revenue for the quarter reached $4.89B.
Earnings released on 30 Sept 2021
EPS came in at $0.92, while revenue for the quarter reached $5.14B.
Dividend declared on 8 Sept 2021
A dividend of $0.83 per share was announced, adjusted to $0.83. The dividend was paid on 30 Sept 2021.
Dividend declared on 8 Jun 2021
A dividend of $0.83 per share was announced, adjusted to $0.83. The dividend was paid on 30 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at $29.29, while revenue for the quarter reached $4.36B.
Dividend declared on 9 Mar 2021
A dividend of $0.83 per share was announced, adjusted to $0.83. The dividend was paid on 31 Mar 2021.
Earnings released on 31 Dec 2020
EPS came in at $3.34, while revenue for the quarter reached $5.32B.
Dividend declared on 9 Dec 2020
A dividend of $0.83 per share was announced, adjusted to $0.83. The dividend was paid on 31 Dec 2020.
Earnings released on 30 Sept 2020
EPS came in at $0.36, while revenue for the quarter reached $4.78B.
Dividend declared on 8 Sept 2020
A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 30 Sept 2020.
0R19.L Stock Performance
Access detailed 0R19.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.